FunPep

Notice Concerning the Completion of Subject Enrollment for the Phase I/IIa Clinical Study of Antibody-Inducing Peptide FPP003

Announcement of the start of joint research with Kumamoto University

Notice of Agreement between FunPep and EPS Innovative Medicine on Collaboration in China Business